Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Free Report) has been assigned an average rating of “Hold” from the eight analysts that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $102.25.
ACLS has been the topic of several recent research reports. Weiss Ratings restated a “hold (c-)” rating on shares of Axcelis Technologies in a report on Monday, December 22nd. Zacks Research cut shares of Axcelis Technologies from a “strong-buy” rating to a “hold” rating in a report on Friday, December 5th. B. Riley boosted their price target on shares of Axcelis Technologies from $84.00 to $94.00 and gave the stock a “neutral” rating in a report on Wednesday, January 21st. Benchmark raised shares of Axcelis Technologies from a “hold” rating to a “buy” rating and set a $105.00 price objective on the stock in a research report on Thursday, October 2nd. Finally, DA Davidson lifted their price objective on shares of Axcelis Technologies from $90.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, October 2nd.
Read Our Latest Research Report on Axcelis Technologies
Axcelis Technologies Trading Up 2.1%
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last released its earnings results on Tuesday, November 4th. The semiconductor company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.01 by $0.20. The company had revenue of $213.61 million for the quarter, compared to analyst estimates of $200.06 million. Axcelis Technologies had a net margin of 15.93% and a return on equity of 14.58%. The firm’s quarterly revenue was down 16.8% on a year-over-year basis. During the same period in the prior year, the business earned $1.49 EPS. Axcelis Technologies has set its Q4 2025 guidance at 1.120-1.120 EPS. Equities research analysts predict that Axcelis Technologies will post 2.55 EPS for the current fiscal year.
Insider Activity
In other news, EVP Gerald M. Blumenstock sold 3,034 shares of the stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $89.46, for a total value of $271,421.64. Following the transaction, the executive vice president owned 18,661 shares in the company, valued at approximately $1,669,413.06. This represents a 13.98% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Jorge Titinger sold 2,000 shares of the business’s stock in a transaction that occurred on Wednesday, December 17th. The stock was sold at an average price of $86.05, for a total value of $172,100.00. Following the sale, the director owned 7,477 shares of the company’s stock, valued at approximately $643,395.85. The trade was a 21.10% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.48% of the company’s stock.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of the stock. American Century Companies Inc. increased its position in shares of Axcelis Technologies by 45.5% during the second quarter. American Century Companies Inc. now owns 1,659,463 shares of the semiconductor company’s stock worth $115,648,000 after purchasing an additional 518,968 shares in the last quarter. Reinhart Partners LLC. grew its position in shares of Axcelis Technologies by 6.0% during the third quarter. Reinhart Partners LLC. now owns 1,610,332 shares of the semiconductor company’s stock worth $157,234,000 after acquiring an additional 91,788 shares during the last quarter. Victory Capital Management Inc. increased its holdings in shares of Axcelis Technologies by 9.6% in the 3rd quarter. Victory Capital Management Inc. now owns 972,162 shares of the semiconductor company’s stock valued at $90,243,000 after acquiring an additional 85,407 shares during the period. Primecap Management Co. CA boosted its stake in Axcelis Technologies by 2.1% during the 2nd quarter. Primecap Management Co. CA now owns 852,296 shares of the semiconductor company’s stock worth $59,397,000 after purchasing an additional 17,230 shares during the period. Finally, Boston Trust Walden Corp increased its stake in Axcelis Technologies by 2.4% in the second quarter. Boston Trust Walden Corp now owns 845,911 shares of the semiconductor company’s stock valued at $58,952,000 after purchasing an additional 19,579 shares during the period. Institutional investors and hedge funds own 89.98% of the company’s stock.
About Axcelis Technologies
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
Featured Stories
- Five stocks we like better than Axcelis Technologies
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The biggest scam in the history of gold markets is unwinding
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
